Navigation Links
Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
Date:9/6/2007

PHILADELPHIA, Sept. 6, 2007 /PRNewswire-FirstCall/ -- CIGNA Group Insurance today announced that Allen Woolf, M.D. has been appointed as chief medical officer. Woolf will have responsibility for managing the clinical aspects of the company's programs that help promote health and wellness, absence management and productivity.

In this role, Dr. Woolf will work with clinical and business leaders for CIGNA Group Insurance's disability, life and accident products and services and Intracorp's workers' compensation programs. As the leader of the company's clinical community, Dr. Woolf will collaborate closely with the physicians, nurses, vocational rehabilitation specialists and other clinical staff who manage CIGNA programs that help people return to work quickly and safely.

"Allen possesses extensive knowledge of the disability and group health industries, which positions him well for this clinical leadership role," said Karen Rohan, president of CIGNA Group Insurance and CIGNA Dental. "In addition, Allen's wealth of experience will contribute significantly to furthering CIGNA's overall goal of improving the health, well-being and security of the individuals we serve."

Dr. Woolf most recently served as the medical officer for CIGNA Behavioral Health/CareAllies. During his 23-year career with CIGNA, Woolf has been extensively involved in the creation and ongoing management of population health improvement programs. He has also held medical leadership positions with CIGNA HealthCare, Intracorp and CareAllies. A graduate of Harvard University School of Medicine, Woolf is board-certified in Pediatrics and is licensed in the states of Pennsylvania, Missouri, Arizona and Connecticut.

Woolf is a member of the Health Management Strategic Advisory Council of The Institute for Health and Productivity Management, a member of the Health Industry Forum and a Fellow of the American Academy of Pediatrics. He recently completed service as a member of the Board of Directors for the Disease Management Association of America. During his career, he has held numerous leadership and committee positions in medical societies, hospitals and industry and government task forces. Dr. Woolf is also involved in his local community, serving as a member of the Board of Directors of Philabundance, a Philadelphia-area food bank.

About CIGNA Group Insurance:

CIGNA Group Insurance products and services are provided by Life Insurance Company of North America and other CIGNA companies. These companies provide group, disability, life and accident coverage in the United States, and are one of the top five providers in disability management and insurance with solutions that focus on helping employees return to a productive work life as quickly and safely as possible. These companies are also one of the top five providers of group term life and group universal life, and the second leading provider of group accident insurance, including voluntary accident and business travel accident insurance. "CIGNA" and "CIGNA Group Insurance" are registered service marks of CIGNA Intellectual Property, Inc. licensed for use by these companies.


'/>"/>
SOURCE CIGNA Group Insurance
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Dr Reddy’s Laboratories to challenge patents on drug
2. Finding relief from Excruciating Headaches a challenge
3. ‘Never Say Die’ Spirit of Visually Challenged - Makes Him a Role Modl
4. Momentum of Stem cell research impeded by legal challenges
5. Australia Ready to Meet the Challenges of Bird Flu
6. OpenMED Nominated For Stockholm Challenge 2006 Award
7. Sexual Health Service Is Under Pressure and Faced With Financial Challenges
8. Treating Bad Breath Yet A Challenge
9. Sexy Images and Lingerie Challenge A Man’s Decision Making Skill
10. Distressed Couple Assists Parents Of Mentally Challenged Kids
11. Abuja Challenges the Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... 2017 , ... East Los Angeles dentist, Ramin Assili DDS , comments ... happens to a woman during pregnancy can have profound effects on a developing fetus, ... on a baby’s long-term health. This study, which was performed at the University of ...
(Date:6/26/2017)... Torrance, CA (PRWEB) , ... June 26, 2017 , ... ... treatments. Smile aesthetics can be one of the most noticeable aspects of a person’s ... approachable. While not everyone is born with beautiful, balanced teeth, everyone can have the ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... & Sexual Medicine Specialists, in collaboration with the Fertility Center of California, is ... care: PESA (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These ...
(Date:6/26/2017)... SALISBURY, MD. (PRWEB) , ... June 26, 2017 ... ... their crop, according to a recent review of government data released by the ... continuous improvement in management practices, Maryland’s soybean farmers have increased their productivity on ...
(Date:6/26/2017)... Lake Tahoe, CA (PRWEB) , ... June 26, 2017 , ... ... seeking 10,000 qualified mental health professionals in every state across the country to join ... an easy and rewarding way for therapists to reach a substantially greater number of ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
Breaking Medicine Technology: